Safety and efficacy of lopinavir/ritonavir combination in COVID-19: A systematic review, meta-analysis, and meta-regression analysis.

Bhattacharyya, Anusuya; Kumar, Subodh; Sarma, Phulen; Kaur, Hardeep; Prajapat, Manisha; Shekhar, Nishant; Bansal, Seema; Avti, Pramod; Hazarika, Mythili; Sharma, Saurabh; Mahendru, Dhruv; Prakash, Ajay; Medhi, Bikash

Bhattacharyya, Anusuya; Kumar, Subodh; Sarma, Phulen; Kaur, Hardeep; Prajapat, Manisha; Shekhar, Nishant; Bansal, Seema; Avti, Pramod; Hazarika, Mythili; Sharma, Saurabh; Mahendru, Dhruv; Prakash, Ajay; Medhi, Bikash.

Afiliación

Bhattacharyya A; Department of Ophthalmology, Government Medical College and Hospital, Sector 32, Chandigarh, India.
Kumar S; Department of Pharmacology, Post Graduate Institute of Medical Education and Research, Chandigarh, Chandigarh, India.
Sarma P; Department of Pharmacology, Post Graduate Institute of Medical Education and Research, Chandigarh, Chandigarh, India.
Kaur H; Department of Pharmacology, Post Graduate Institute of Medical Education and Research, Chandigarh, Chandigarh, India.
Prajapat M; Department of Pharmacology, Post Graduate Institute of Medical Education and Research, Chandigarh, Chandigarh, India.
Shekhar N; Department of Pharmacology, Post Graduate Institute of Medical Education and Research, Chandigarh, Chandigarh, India.
Bansal S; Department of Pharmacology, Post Graduate Institute of Medical Education and Research, Chandigarh, Chandigarh, India.
Avti P; Department of Biophysics, Post Graduate Institute of Medical Education and Research, Chandigarh, Chandigarh, India.
Hazarika M; Department of Psychiatry, Gauhati Medical College and Hospital, Guwahati, Assam, India.
Sharma S; Department of Pharmacology, Post Graduate Institute of Medical Education and Research, Chandigarh, Chandigarh, India.
Mahendru D; Department of Pharmacology, Post Graduate Institute of Medical Education and Research, Chandigarh, Chandigarh, India.
Prakash A; Department of Pharmacology, Post Graduate Institute of Medical Education and Research, Chandigarh, Chandigarh, India.
Medhi B; Department of Pharmacology, Post Graduate Institute of Medical Education and Research, Chandigarh, Chandigarh, India.

Indian J Pharmacol ; 52(4): 313-323, 2020.

Article en En | MEDLINE | ID: mdl-33078733

Asunto(s)

Antivirales/uso terapéutico; Infecciones por Coronavirus/tratamiento farmacológico; Lopinavir/uso terapéutico; Neumonía Viral/tratamiento farmacológico; Ritonavir/uso terapéutico; COVID-19; Combinación de Medicamentos; Humanos; Resultados Negativos; Pandemias; Resultado del Tratamiento; Tratamiento Farmacológico de COVID-19

Palabras clave

A: Arbidol; ADR: Adverse drug reaction; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; COVID-19; COVID-19: Corona virus disease-19; CQ: Chloroquine; HCQ: Hydroxy chloroquine; IFN: Interferon; MD: Mean difference; OR: Odd ratio; SOC: Standard of care; lopinavir; meta-analysis; ritonavir Abbreviations: L/R: Lopinavir + Ritonavir

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antivirales / Neumonía Viral / Infecciones por Coronavirus / Ritonavir / Lopinavir Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Indian J Pharmacol Año: 2020 Tipo del documento: Article País de afiliación: India Pais de publicación: India

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google